OTC - ACTIVE INGREDIENT SECTION
Titanium Dioxide 9.455%
Octinoxate 4.000%
Zinc Oxide 0.980%
Dr. Jart DIS-A-PORE Beauty Balm
- Manufacturer
- Have and Be Co., Ltd. | Cosmax, Inc.
- Effective date
- 2017-01-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:17:31
Label at a glance#
ProductDr. Jart DIS-A-PORE Beauty Balm
Active ingredientTitanium Dioxide, Zinc Oxide, OCTINOXATE
Label structure9 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Sunscreen
INDICATIONS & USAGE SECTION
Helps prevent sunburn
If used as directed with other sun protection meausres (see Directions), decreases the risk of skin cancer and early skin aging casued by the sun
DOSAGE & ADMINISTRATION SECTION
- Apply liberally 15 minutes before sun exposure
- Use a water resistant sunscreen if swimming or sweating
- Reapply at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
– Limit time in the sun, especially from 10 am - 2 pm
– Wear long-sleeved shirts, pants, hats and sunglasses
- Ask a doctor to use for children under 6 months
WARNINGS SECTION
For external use only.
Do not use on damaged or broken skin.
When using this product, keep out of eyes. Rinse with water to remove.
Stop using and ask a doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of the children. If product is swallowed, get medical help or contact a poison control center right away.
INACTIVE INGREDIENT SECTION
Water
Cyclomethicone 5
Dimethicone
Butylene Glycol
Niacinamide
Pentylene Glycol
Disteardimonium Hectorite
Cyclomethicone
C30-45 Alkyl Methicone
Methyl Methacrylate
Ferric Oxide Red
Triethoxycaprylylsilane
Aluminum Hydroxide
Stearic Acid
Ethylhexylglycerin
Adenosine
Disodium Edta-Copper
Cananga Odorata Flower
Chamaecyparis Obtusa Wood Oil
Lavender Oil
Rosemary Oil
Mentha X Rotundifolia Leaf
Chamomile Flower Oil
Peppermint Oil
Hibiscus Sabdariffa Flower
Jasminum Officinale Flower
Argania Spinosa Seed
Sodium Cocoyl Glutamate
Rosa Multiflora Fruit
Carbomer Homopolymer Type C (Allyl Pentaerythritol Crosslinked
Propyl Gallate
OTHER SAFETY INFORMATION
Protect the product in this container from excessive heat and direct sunlight
You may report a serious adverse event from use of this product to: Report Reaction, LLC PO Box 22 Plainsboro, NJ 08536-0222
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 4 | |
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 4 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 4 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 4 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 4 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 4 | |
| Adenosine | INACTIVE INGREDIENT | K72T3FS567 | 4 | |
| Aluminum Hydroxide | INACTIVE INGREDIENT | 5QB0T2IUN0 | 4 | |
| ARGANIA SPINOSA SEED | INACTIVE INGREDIENT | 8H7X7XB54H | 4 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 4 | |
| C30-45 ALKYL METHICONE | INACTIVE INGREDIENT | NFX970DSI2 | 4 | |
| CANANGA ODORATA FLOWER | INACTIVE INGREDIENT | 76GTF6Z97M | 4 | |
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | INACTIVE INGREDIENT | 4Q93RCW27E | 4 | |
| CHAMAECYPARIS OBTUSA WOOD OIL | INACTIVE INGREDIENT | P2OMP71Y62 | 4 | |
| CHAMOMILE FLOWER OIL | INACTIVE INGREDIENT | 60F80Z61A9 | 4 | |
| Cyclomethicone | INACTIVE INGREDIENT | NMQ347994Z | 4 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 4 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 4 | |
| DISODIUM EDTA-COPPER | INACTIVE INGREDIENT | 6V475AX06U | 4 | |
| Disteardimonium Hectorite | INACTIVE INGREDIENT | X687XDK09L | 4 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 4 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 4 | |
| HIBISCUS SABDARIFFA FLOWEr | INACTIVE INGREDIENT | 45TGG6IU6M | 4 | |
| JASMINUM OFFICINALE FLOWER | INACTIVE INGREDIENT | 0Q8K841432 | 4 | |
| LAVENDER OIL | INACTIVE INGREDIENT | ZBP1YXW0H8 | 4 | |
| MENTHA X ROTUNDIFOLIA LEAF | INACTIVE INGREDIENT | K59TXG2L3U | 4 | |
| METHYL METHACRYLATE | INACTIVE INGREDIENT | 196OC77688 | 4 | |
| Niacinamide | INACTIVE INGREDIENT | 25X51I8RD4 | 4 | |
| Pentylene Glycol | INACTIVE INGREDIENT | 50C1307PZG | 4 | |
| PEPPERMINT OIL | INACTIVE INGREDIENT | AV092KU4JH | 4 | |
| Propyl Gallate | INACTIVE INGREDIENT | 8D4SNN7V92 | 4 | |
| ROSA MULTIFLORA FRUIT | INACTIVE INGREDIENT | EZ5DSL4T27 | 4 | |
| ROSEMARY OIL | INACTIVE INGREDIENT | 8LGU7VM393 | 4 | |
| SODIUM COCOYL GLUTAMATE | INACTIVE INGREDIENT | BMT4RCZ3HG | 4 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 4 | |
| Triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 4 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Products#
Every source-derived product name is available through these pages.
- Dr. Jart DIS-A-PORE Beauty Balm
- Titanium Dioxide, Octinoxate, Zinc Oxide
- Titanium Dioxide
- Zinc Oxide
- ZINC CATION
- OCTINOXATE
- Water
- CYCLOMETHICONE 5
- Dimethicone
- Butylene Glycol
- Niacinamide
- Pentylene Glycol
- Disteardimonium Hectorite
- Cyclomethicone
- C30-45 ALKYL METHICONE
- METHYL METHACRYLATE
- FERRIC OXIDE RED
- Triethoxycaprylylsilane
- Aluminum Hydroxide
- Stearic Acid
- Ethylhexylglycerin
- Adenosine
- DISODIUM EDTA-COPPER
- CANANGA ODORATA FLOWER
- CHAMAECYPARIS OBTUSA WOOD OIL
- LAVENDER OIL
- ROSEMARY OIL
- MENTHA X ROTUNDIFOLIA LEAF
- CHAMOMILE FLOWER OIL
- PEPPERMINT OIL
- HIBISCUS SABDARIFFA FLOWEr
- JASMINUM OFFICINALE FLOWER
- ARGANIA SPINOSA SEED
- SODIUM COCOYL GLUTAMATE
- ROSA MULTIFLORA FRUIT
- CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)
- Propyl Gallate
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49404-202 | 49404-202-01, 49404-202-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | POWDER, DENTIFRICE / DENTAL | NA | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET / ORAL | 28 mg | ||
| Propyl Gallate | PROPYL GALLATE | 8D4SNN7V92 | TABLET / ORAL | 7 mg | ||
| Propyl Gallate | PROPYL GALLATE | 8D4SNN7V92 | TABLET, EXTENDED RELEASE / ORAL | 1 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | EMULSION / TOPICAL | 6 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 3.6 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SUSPENSION / ORAL | 100 mg/1ml | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | CREAM, AUGMENTED / TOPICAL | 7.6 %w/w | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL / TOPICAL | 85 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | POWDER / SUBLINGUAL | 1 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| Aluminum Hydroxide | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CAPSULE / ORAL | NA | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| Propyl Gallate | PROPYL GALLATE | 8D4SNN7V92 | CONCENTRATE / ORAL | 0.2 mg/1ml | ||
| Propyl Gallate | PROPYL GALLATE | 8D4SNN7V92 | SUSPENSION, EXTENDED RELEASE / ORAL | 4 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SHAMPOO / TOPICAL | 0.2 %w/w | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| Aluminum Hydroxide | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | OINTMENT / TOPICAL | NA | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | CONCENTRATE / ORAL | 0.05 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | FILM / BUCCAL | 12 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL, METERED / TRANSDERMAL | 50 mg | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | GUM, CHEWING / ORAL | 526 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | CREAM, AUGMENTED / TOPICAL | 20 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | LOTION / TOPICAL | 300 mg | ||
| Propyl Gallate | PROPYL GALLATE | 8D4SNN7V92 | GEL / TOPICAL | 0.05 %w/w | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | LOTION / TOPICAL | NA | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | PASTE, DENTIFRICE / DENTAL | 49.3 %w/w | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED PELLETS / ORAL | 2 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | ELIXIR / ORAL | 0.04 mg/1ml | ||
| Propyl Gallate | PROPYL GALLATE | 8D4SNN7V92 | CREAM / TOPICAL | NA | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SPRAY, METERED / SUBLINGUAL | 1 mg | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | GEL / TOPICAL | 25 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / SUBLINGUAL | 1 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET / SUBLINGUAL | 0.15 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SOLUTION / ORAL | 53 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| Propyl Gallate | PROPYL GALLATE | 8D4SNN7V92 | CAPSULE / ORAL | 7 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, DELAYED RELEASE / ORAL | 14 mg | ||
| LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | INHALANT / NASAL | NA | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | CREAM / TOPICAL | 103 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9a13e6b8-7480-9cd4-e053-2a95a90afafb | 57d1d256-4e1f-45df-992b-4c47f10ceb60 | 2019-12-19 | Warnings | 57d1d256-4e1f-45df-992b-4c47f10ceb60 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.